Cargando…

Hypertriglyceridemia Causing Continuous Renal Replacement Therapy Dysfunction in a Patient with End-stage Liver Disease

Hypertriglyceridemia is infrequently reported as a cause of suboptimal delivery of dialytic therapy in critically ill patients. We report the case of a critically ill liver transplant patient in the Intensive Care Unit who was found to have recurrent filter clotting during continuous renal replaceme...

Descripción completa

Detalles Bibliográficos
Autores principales:	McLaughlin, D. C., Fang, D. C., Nolot, B. A., Guru, P. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094843/ https://www.ncbi.nlm.nih.gov/pubmed/30158750 http://dx.doi.org/10.4103/ijn.IJN_201_17

Ejemplares similares

Continuous renal replacement therapy outcomes in acute kidney injury and end-stage renal disease: a cohort study
por: Allegretti, Andrew S, et al.
Publicado: (2013)

Nursing Countermeasures of Continuous Renal Replacement Treatment in End-Stage Renal Disease with Refractory Hypotension in the Context of Smart Health
por: Ma, Liya, et al.
Publicado: (2022)

Causes and Consequences of Hypertriglyceridemia
por: Packard, Chris J., et al.
Publicado: (2020)

End-Stage Renal Disease and Renal Replacement Therapy in older Patients
por: Smyth, Andrew
Publicado: (2012)

Renal replacement therapy in Latin American end-stage renal disease
por: Rosa-Diez, Guillermo, et al.
Publicado: (2014)

Familial hypertriglyceridemia: an entity with distinguishable features from other causes of hypertriglyceridemia
por: Cruz-Bautista, Ivette, et al.
Publicado: (2021)

Seasonal variations in cause-specific mortality and transition to renal replacement therapy among patients with end-stage renal disease
por: Goto, Shunsuke, et al.
Publicado: (2020)

Treatment of Severe Hypertriglyceridemia with Continuous Insulin Infusion
por: Rodríguez Santana, Yesica, et al.
Publicado: (2011)

Glymphatic Dysfunction in Patients With End-Stage Renal Disease
por: Heo, Chang Min, et al.
Publicado: (2022)

Cell therapy in end-stage liver disease: replace and remodel
por: Hu, Xin-Hao, et al.
Publicado: (2023)

Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction
por: Klingele, Matthias, et al.
Publicado: (2017)

Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy
por: Kade, Grzegorz, et al.
Publicado: (2012)

The Role of Hypertriglyceridemia in the Development of Atherosclerosis and Endothelial Dysfunction
por: Matsumoto, Saki, et al.
Publicado: (2014)

Incidence and Predictors of End Stage Renal Disease among Low-Income Blacks and Whites
por: Lipworth, Loren, et al.
Publicado: (2012)

Dendritic Cell Dysfunction in Patients with End-stage Renal Disease
por: Kim, Ji Ung, et al.
Publicado: (2017)

Hypertriglyceridemia—Causes, Significance, and Approaches to Therapy
por: Santos-Baez, Leinys S., et al.
Publicado: (2020)

Organophosphorus Flame Retardants Inhibit Specific Liver Carboxylesterases and Cause Serum Hypertriglyceridemia
por: Morris, Patrick J., et al.
Publicado: (2014)

The Effect of Renal Transplantation in End-Stage Renal Failure Patients Undergoing Total Hip Replacement
por: Rong Lim, Winston Shang, et al.
Publicado: (2019)

Coronary microvascular dysfunction is associated with degree of anaemia in end‐stage renal disease
por: Radhakrishnan, Ashwin, et al.
Publicado: (2021)

Basics of continuous renal replacement therapy in pediatrics
por: John, Jacob C., et al.
Publicado: (2019)

Clinical application of regional citrate anticoagulation for continuous renal replacement therapy in children with liver injury
por: Hu, Fang, et al.
Publicado: (2022)

Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion
por: Pulipati, Vishnu Priya, et al.
Publicado: (2021)

Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure
por: Rodriguez, Keila, et al.
Publicado: (2017)

Dilated cardiomyopathy secondary to acute pancreatitis caused by hypertriglyceridemia
por: Greer, Jordan W, et al.
Publicado: (2018)

Tamoxifen-induced hypertriglyceridemia causing acute pancreatitis
por: Singh, Hemant Kumar, et al.
Publicado: (2016)

Hypertriglyceridemia - Common Causes, Prevention and treatment Strategies
por: Rygiel, Katarzyna
Publicado: (2018)

A Case of Profound Hypertriglyceridemia Causing Pseudohypobicarbonatemia
por: Garg, Deepshikha, et al.
Publicado: (2023)

Continuous renal replacement therapy and its impact on hyperammonaemia in acute liver failure
por: Warrillow, Stephen, et al.
Publicado: (2023)

Hypertriglyceridemia
por: Brahm, Amanda, et al.
Publicado: (2013)

Hypogonadism and testosterone replacement therapy in end-stage renal disease (ESRD) and transplant patients
por: Snyder, Grace, et al.
Publicado: (2016)

Calciphylaxis After Aortic Valve Replacement in a Patient with End-Stage Renal Disease
por: Hirooka, Kazunobu, et al.
Publicado: (2021)

Cause of postoperative mortality in patients with end-stage renal disease
por: Song, Sanghoon, et al.
Publicado: (2022)

Renal replacement therapy for acute renal failure in the intensive care unit is associated with a worse prognosis than renal replacement therapy for end-stage renal failure
por: Ostermann, M, et al.
Publicado: (2005)

Transcatheter Aortic Valve Replacement Outcomes in End-Stage Renal Disease Patients on Hemodialysis Requiring Midodrine
por: Korngold, Ethan C., et al.
Publicado: (2023)

The Genetic Basis of Hypertriglyceridemia
por: Carrasquilla, Germán D., et al.
Publicado: (2021)

Treatment of end-stage renal disease with continuous ambulatory peritoneal dialysis in rural Guatemala
por: Moore, Jillian, et al.
Publicado: (2018)

Long‐Term Outcomes of Transcatheter Aortic Valve Replacement in Patients With End‐Stage Renal Disease
por: Ogami, Takuya, et al.
Publicado: (2021)

POS-950 COVID-19 IN END STAGE KIDNEY DISEASE WITH RENAL REPLACEMENT THERAPIES: OUR EXPERIENCE IN PENANG
por: LEE, S.Y., et al.
Publicado: (2022)

Optimal stage of initiating continuous renal replacement therapy in the treatment of neonatal acute kidney injury
por: Zhang, Xiaoyue, et al.
Publicado: (2022)

Protein losses in continuous renal replacement therapies
por: Rodigues, MG, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_gcbs93kh1tthb3gg6qbps88fat